Noteworthy molecular insights emerged from the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, indicating a common upregulation of the PI3K/AKT pathway signaling in HER2-altered NSCLC. Here, ERBB2 is linked to non-small cell lung carcinoma.